Tag: pharma QA

Addressing Tablet Capping Issues Following Scale-Up: A Comprehensive Investigation Framework Tablet capping is a significant manufacturing concern that can arise during the scale-up of solid oral dosage forms. This article…

Addressing Weight Variation Issues Following Equipment Maintenance in Pharmaceutical Manufacturing In the highly regulated environment of pharmaceutical manufacturing, maintaining product quality is paramount. Weight variation issues, particularly after maintenance activities,…

Understanding and Documenting Hardness Drift Following Excipient Changes in Pharmaceutical Manufacturing In the realm of pharmaceutical manufacturing, the quality attributes of solid oral dosage forms, such as tablets and capsules,…

Challenges in Tablet Lamination Following Scale-Up: Investigating Process Parameter Limits and Validation Effects Quality assurance teams in pharmaceutical manufacturing often face challenges during the scale-up of tablet lamination processes. An…

Investigating Disintegration Failures during Continuous Process Verification Reviews In pharmaceutical manufacturing, ensuring the integrity and efficacy of solid oral dosage forms, such as tablets and capsules, is crucial. A common…

Investigating Disintegration Failures Following Stability Pulls: Effective Troubleshooting Techniques Disintegration failures post-stability pull can pose significant challenges in pharmaceutical manufacturing, affecting product quality and regulatory compliance. This issue demands a…

Investigating Capsule Fill Weight Variation During CPV Review: Understanding Process Parameter Limits and Validation Impacts Capsule fill weight variation is a common issue observed in pharmaceutical manufacturing, particularly during the…

Investigating Friability Failures during High-Speed Tablet Runs in Pharma Manufacturing Friability failures during high-speed runs present a significant challenge in pharmaceutical manufacturing, particularly for solid oral dosage forms like tablets.…

Dissolution Issues During High-Speed Runs: Conducting a Root Cause Investigation with CAPA Framework In the highly regulated environment of pharmaceutical manufacturing, a dissolution failure during high-speed runs can significantly impact…

Addressing Capsule Fill Weight Variation Post-Maintenance: How to Meet FDA and EMA Documentation Standards In pharmaceutical manufacturing, the integrity of capsule fill weights is critical for compliance with both FDA…

Understanding Assay Drift In Stability Testing: Investigative Approaches To Prevent Repeat OOS Findings In the realm of pharmaceutical manufacturing, assay drift on stability can lead to unexpected out-of-specification (OOS) results,…

Investigating Disintegration Failure in Multi-Strength Campaigns: Effective Sampling Plan Fixes to Prevent Repeat OOS Events In the realm of pharmaceutical manufacturing, the integrity of dosage forms is paramount. Disintegration failure…